Oval Cell Marker Antibody (OC2-2F3) [Allophycocyanin/Cy7]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-18964APCCY7
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Frozen
Label
Allophycocyanin/Cy7 (Excitation = 650;755 nm, Emission = 767 nm)
Antibody Source
Monoclonal Rat IgG1 Clone # OC2-2F3
Concentration
This product is unpurified. The exact concentration of antibody is not quantifiable.
Product Specifications
Immunogen
Nonparenchymal cells from DDC-treated mice
Localization
Cell surface
Specificity
Specific for proliferating hepatic duct cells.
Marker
Hepatic periductal cell Marker
Clonality
Monoclonal
Host
Rat
Isotype
IgG1
Applications for Oval Cell Marker Antibody (OC2-2F3) [Allophycocyanin/Cy7]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Frozen
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Tissue culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
This product is unpurified. The exact concentration of antibody is not quantifiable.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark. Do not freeze.
Background: Oval Cell Marker
Additional Oval Cell Marker Products
Product Documents for Oval Cell Marker Antibody (OC2-2F3) [Allophycocyanin/Cy7]
Product Specific Notices for Oval Cell Marker Antibody (OC2-2F3) [Allophycocyanin/Cy7]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...